Erythromycin

Product NDC: 55289-025
Requested package NDC: 55289-025-04
11-digit product format: 552890025
Labeler code: 55289
Product ID: 55289-025_e6e99fde-0aed-67d8-e053-2a95a90a32b4
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Erythromycin
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: PD-Rx Pharmaceuticals, Inc.
Application: ANDA061621
Marketing category: ANDA
Marketing start: 2011-09-06
Marketing end: 0000-00-00
Substance: ERYTHROMYCIN
Active strength: 500 mg/1
Pharmacologic classes: Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	55289-025	55289-025-04	D	Discontinued by firm		2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 1 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Archive	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	55289-025	55289-025-04	D	Discontinued by firm		excluded / ndc_excluded.zip	`d630ba8d3edf…`	`732f749b63fb…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A061621-001	ERYTHROMYCIN	ERYTHROMYCIN	250MG	TABLET / ORAL	AB	Approved before 1982
A061621-002	ERYTHROMYCIN	ERYTHROMYCIN	500MG	TABLET / ORAL	AB	Approved before 1982

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A061621-001	AB
A061621-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A061621-001	ERYTHROMYCIN	250MG	TABLET / ORAL	AB	Approved before 1982	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A061621-002	ERYTHROMYCIN	500MG	TABLET / ORAL	AB	Approved before 1982	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A061621-001	ERYTHROMYCIN	250MG	TABLET / ORAL	AB	Approved before 1982	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A061621-002	ERYTHROMYCIN	500MG	TABLET / ORAL	AB	Approved before 1982	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A061621-001	ERYTHROMYCIN	250MG	TABLET / ORAL	AB	Approved before 1982	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A061621-002	ERYTHROMYCIN	500MG	TABLET / ORAL	AB	Approved before 1982	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A061621-001	ERYTHROMYCIN	250MG	TABLET / ORAL	AB	Approved before 1982	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A061621-002	ERYTHROMYCIN	500MG	TABLET / ORAL	AB	Approved before 1982	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A061621-001	ERYTHROMYCIN	250MG	TABLET / ORAL	AB	Approved before 1982	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A061621-002	ERYTHROMYCIN	500MG	TABLET / ORAL	AB	Approved before 1982	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A061621-001	ERYTHROMYCIN	250MG	TABLET / ORAL	AB	Approved before 1982	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A061621-002	ERYTHROMYCIN	500MG	TABLET / ORAL	AB	Approved before 1982	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A061621-001	ERYTHROMYCIN	250MG	TABLET / ORAL	AB	Approved before 1982	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A061621-002	ERYTHROMYCIN	500MG	TABLET / ORAL	AB	Approved before 1982	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A061621-001	ERYTHROMYCIN	250MG	TABLET / ORAL	AB	Approved before 1982	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A061621-002	ERYTHROMYCIN	500MG	TABLET / ORAL	AB	Approved before 1982	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A061621-001	ERYTHROMYCIN	250MG	TABLET / ORAL	AB	Approved before 1982	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A061621-002	ERYTHROMYCIN	500MG	TABLET / ORAL	AB	Approved before 1982	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A061621-001	ERYTHROMYCIN	250MG	TABLET / ORAL	AB	Approved before 1982	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A061621-002	ERYTHROMYCIN	500MG	TABLET / ORAL	AB	Approved before 1982	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A061621-001	ERYTHROMYCIN	250MG	TABLET / ORAL	AB	Approved before 1982	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A061621-002	ERYTHROMYCIN	500MG	TABLET / ORAL	AB	Approved before 1982	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A061621-001	ERYTHROMYCIN	250MG	TABLET / ORAL	AB	Approved before 1982	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A061621-002	ERYTHROMYCIN	500MG	TABLET / ORAL	AB	Approved before 1982	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A061621-001	ERYTHROMYCIN	250MG	TABLET / ORAL	AB	Approved before 1982	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A061621-002	ERYTHROMYCIN	500MG	TABLET / ORAL	AB	Approved before 1982	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A061621-001	ERYTHROMYCIN	250MG	TABLET / ORAL	AB	Approved before 1982	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A061621-002	ERYTHROMYCIN	500MG	TABLET / ORAL	AB	Approved before 1982	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A061621-001	ERYTHROMYCIN	250MG	TABLET / ORAL	AB	Approved before 1982	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A061621-002	ERYTHROMYCIN	500MG	TABLET / ORAL	AB	RS, Approved before 1982	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A061621-001	ERYTHROMYCIN	250MG	TABLET / ORAL	AB	Approved before 1982	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A061621-002	ERYTHROMYCIN	500MG	TABLET / ORAL	AB	RS, Approved before 1982	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A061621-001	ERYTHROMYCIN	250MG	TABLET / ORAL	AB	Approved before 1982	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A061621-002	ERYTHROMYCIN	500MG	TABLET / ORAL	AB	RS, Approved before 1982	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A061621-001	ERYTHROMYCIN	250MG	TABLET / ORAL	AB	Approved before 1982	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A061621-002	ERYTHROMYCIN	500MG	TABLET / ORAL	AB	RS, Approved before 1982	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A061621-001	ERYTHROMYCIN	250MG	TABLET / ORAL	AB	Approved before 1982	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A061621-002	ERYTHROMYCIN	500MG	TABLET / ORAL	AB	RS, Approved before 1982	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A061621-001	ERYTHROMYCIN	250MG	TABLET / ORAL	AB	Approved before 1982	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A061621-002	ERYTHROMYCIN	500MG	TABLET / ORAL	AB	RS, Approved before 1982	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A061621-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A061621-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A061621-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A061621-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A061621-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A061621-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A061621-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A061621-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A061621-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A061621-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A061621-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A061621-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A061621-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A061621-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A061621-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A061621-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A061621-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A061621-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A061621-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A061621-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A061621-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A061621-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A061621-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A061621-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A061621-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A061621-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A061621-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A061621-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A061621-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A061621-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A061621-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A061621-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A061621-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A061621-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A061621-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A061621-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A061621-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A061621-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A061621-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A061621-002	AB	1	`782e0a99824c…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d329c2e1-5ae8-4e64-aea0-77ecea3fa1ab	Product name	3	20250717
3b331500-3b74-bd2b-fede-d46839f2f4d5	Product name	6	20240313
fdae2630-eae0-4769-abfd-8f33d5b771b4	Product name	3	20240202
8c898317-b543-1e4e-254f-84cec2f3f57e	Product name	2	20191002
64ae94c0-3212-d73a-92da-9e6dd85c6ebe	Product name	2	20180118
edcfa1cf-915f-1a4c-d0aa-508cc66e70d9	Product name	2	20170816
ad75fcfd-a339-42a1-9c60-43ba2c654cfa	Product name	1	20170810
57850177-5927-151f-e1fa-7e2ca47f81e5	Product name	1	20140508
8ee71591-1d8f-e24e-242b-bfef131e3168	Product name	1	20140508
bff5cf99-0f45-fa15-2a76-b160c3c4cc3c	Product name	1	20140508

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
55289-025-04	EA - Each	55289-025	0ec07be5-2cfa-4a15-9805-574e32e2afdc	1	2013-02-13
55289-025-20	EA - Each	55289-025	00f92413-7b54-4e10-88ac-dd88ddfb460f	1	2013-02-13
55289-025-28	EA - Each	55289-025	3c179513-0364-4ad4-8623-8bc513acb145	1	2013-02-13
55289-025-30	EA - Each	55289-025	916f7372-d44f-48ea-8678-7723b25b03b7	1	2013-02-13
55289-025-40	EA - Each	55289-025	6be6ab10-85ac-4e1e-9ea6-de6650d0cacf	1	2013-02-13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Erythromycin	ACTIVE INGREDIENT	63937KV33D	ERYTHROMYCIN BASE (ERYTHROMYCIN) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]	2
Erythromycin	ACTIVE MOIETY	63937KV33D	ERYTHROMYCIN BASE (ERYTHROMYCIN) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]	2
aluminum oxide	INACTIVE INGREDIENT	LMI26O6933	ERYTHROMYCIN BASE (ERYTHROMYCIN) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]	2
cellulose, microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	ERYTHROMYCIN BASE (ERYTHROMYCIN) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]	2
croscarmellose sodium	INACTIVE INGREDIENT	M28OL1HH48	ERYTHROMYCIN BASE (ERYTHROMYCIN) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]	2
crospovidone	INACTIVE INGREDIENT	68401960MK	ERYTHROMYCIN BASE (ERYTHROMYCIN) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]	2
D&C Red No. 30	INACTIVE INGREDIENT	2S42T2808B	ERYTHROMYCIN BASE (ERYTHROMYCIN) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]	2
hydroxypropyl cellulose	INACTIVE INGREDIENT	RFW2ET671P	ERYTHROMYCIN BASE (ERYTHROMYCIN) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]	2
hypromelloses	INACTIVE INGREDIENT	3NXW29V3WO	ERYTHROMYCIN BASE (ERYTHROMYCIN) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]	2
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	ERYTHROMYCIN BASE (ERYTHROMYCIN) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]	2
polyethylene glycols	INACTIVE INGREDIENT	3WJQ0SDW1A	ERYTHROMYCIN BASE (ERYTHROMYCIN) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]	2
povidone	INACTIVE INGREDIENT	FZ989GH94E	ERYTHROMYCIN BASE (ERYTHROMYCIN) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]	2
propylene glycol	INACTIVE INGREDIENT	6DC9Q167V3	ERYTHROMYCIN BASE (ERYTHROMYCIN) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]	2
Silicon Dioxide	INACTIVE INGREDIENT	ETJ7Z6XBU4	ERYTHROMYCIN BASE (ERYTHROMYCIN) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]	2
sodium citrate	INACTIVE INGREDIENT	1Q73Q2JULR	ERYTHROMYCIN BASE (ERYTHROMYCIN) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]	2
sodium hydroxide	INACTIVE INGREDIENT	55X04QC32I	ERYTHROMYCIN BASE (ERYTHROMYCIN) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]	2
sorbic acid	INACTIVE INGREDIENT	X045WJ989B	ERYTHROMYCIN BASE (ERYTHROMYCIN) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]	2
sorbitan monooleate	INACTIVE INGREDIENT	06XEA2VD56	ERYTHROMYCIN BASE (ERYTHROMYCIN) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]	2
talc	INACTIVE INGREDIENT	7SEV7J4R1U	ERYTHROMYCIN BASE (ERYTHROMYCIN) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]	2
titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	ERYTHROMYCIN BASE (ERYTHROMYCIN) TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
55289-025	ERYTHROMYCIN TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]	19	Legacy NDC	20241011_5d19702d-bb87-4f6b-84e5-35424611404a.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Erythromycin	ERYTHROMYCIN	PD-Rx Pharmaceuticals, Inc.	e54d66fa-93bb-4339-a75e-194a2e4488aa	2025-10-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 061621 application number: ANDA061621
Erythromycin	ERYTHROMYCIN	Wilshire Pharmaceuticals	f2efbc94-64f7-4130-ab23-e5983854f730	2019-01-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 061621 application number: ANDA061621
Erythromycin	ERYTHROMYCIN	Arbor Pharmaceuticals, Inc.	ca1326d6-c5c6-4572-96b6-e56cd944799c	2018-12-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 061621 application number: ANDA061621

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
63937KV33D	ERYTHROMYCIN	114-07-8	ERYTHROMYCIN

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
55289-025-04	55289002504	4 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-025-04)	2012-05-04	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
ERYTHROMYCIN TABLETS, USP	PD-Rx Pharmaceuticals, Inc.	2024-10-09	HUMAN PRESCRIPTION DRUG LABEL	19